Free shipping on all orders over $ 500

Erianin

Cat. No. M13464

All AbMole products are for research use only, cannot be used for human consumption.

Erianin Structure
Size Price Availability Quantity
1mg USD 20  USD20 In stock
5mg USD 50  USD50 In stock
10mg USD 80  USD80 In stock
20mg USD 120  USD120 In stock
50mg USD 240  USD240 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

Erianin, a bibenzyl analog isolated from Dendrobium bulbosum, is also a PD-L1 inhibitor that exhibits potential antitumor activity in a variety of malignant tumors.Erianin regulates a variety of cancer-associated pathways in vitro and in vivo, including apoptosis, cell-cycle arrest, invasion, migration, and autophagy. In addition, Erianin inhibits indoleamine-2,3-dioxygenase (IDO)-induced tumor angiogenesis.

Chemical Information
Molecular Weight 318.36
CAS Number 95041-90-0
Solubility (25°C) DMSO 90 mg/mL
Storage 2-8°C, protect from light
References

[1] Yu Xiang, et al. Front Pharmacol. Natural Product Erianin Inhibits Bladder Cancer Cell Growth by Inducing Ferroptosis via NRF2 Inactivation

[2] Yan Wang, et al. J Ethnopharmacol. Erianin, the main active ingredient of Dendrobium chrysotoxum Lindl, inhibits precancerous lesions of gastric cancer (PLGC) through suppression of the HRAS-PI3K-AKT signaling pathway as revealed by network pharmacology and in vitro experimental verificati䲧

[3] Yonggang Xu, et al. Biosci Rep. Erianin induces triple-negative breast cancer cells apoptosis by activating PI3K/Akt pathway

[4] Peng Chen, et al. Signal Transduct Target Ther. Erianin, a novel dibenzyl compound in Dendrobium extract, inhibits lung cancer cell growth and migration via calcium/calmodulin-dependent ferroptosis

[5] Tianyu Zhang, et al. FASEB J. Erianin alleviates diabetic retinopathy by reducing retinal inflammation initiated by microglial cells via inhibiting hyperglycemia-mediated ERK1/2-NF-κB signaling pathway

Related PD-1/PD-L1 Products
PD-1/PD-L1-IN-9

PD-1/PD-L1-IN-9 is a potent and orally active inhibitor of PD-1/PD-L1 interaction, with an IC50 of 3.8 nM. PD-1/PD-L1-IN-9 can enhance the killing activity of tumor cells by immune cells. PD-1/PD-L1-IN-9 also exhibits significant in vivo antitumor activity in a CT26 mouse model.

NSC622608 

NSC622608 is a V-domain Ig suppressor of T-cell activation (VISTA) ligand with an IC50 value of 4.8 μM.

PD-L1-IN-1 

PD-L1-IN-1 is a potent PD-L1 inhibitor with an IC50 of 115 nM.

SL-279252

SL-279252 (PD1-Fc-OX40L) is a hexameric, bi-functional fusion protein with an ECD of PD-1 (70 pM affinity to PD-L1) linked to the ECD of OX40L (324 pM affinity for OX40) through an Fc linker. SL-279252 exhibited linear PK at doses up to 3.0 mg/kg, and a greater than proportional increase in AUC was observed at 6.0 mg/kg suggesting potential receptor saturation. The preliminary half-life is approximately 23 hours.

Rosnilimab

Rosnilimab is a novel PD-1 checkpoint agonist antibody that reduces overactive T cell inflammation. Rosnilimab optimizes PD-1+ T cell inhibitory signaling by enabling tight immune synapse formation. Rosnilimab restores immune balance bringing T cell composition to a less activated state.

  Catalog
Abmole Inhibitor Catalog




Keywords: Erianin supplier, PD-1/PD-L1, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.